Theriva Biologics (TOVX) Return on Capital Employed [ROCE] (2011 - 2026)
Theriva Biologics (TOVX) posted Return on Capital Employed [ROCE] of -48.79% for Q2 2026, up 90.16 percentage points from -138.95% a year earlier and up 28.99 percentage points from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Theriva Biologics' Return on Capital Employed [ROCE] came in at -89.80%, down 19.92 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for three consecutive years, though with a five-year change of +13.27 percentage points (FY2020 to FY2025).
- In prior years, Theriva Biologics' Return on Capital Employed [ROCE] was -69.88% in FY2024 (-32.15 pp), -37.73% in FY2023 (-4.04 pp), -33.69% in FY2022 (+6.14 pp) and -39.83% in FY2021 (+63.24 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2024.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -18.88 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 193.53 percentage points; the weakest was Q2 2025, with a drop of 76.14 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -77.78% (Q1 2026), -98.08% (Q4 2025) and -118.98% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Theriva Biologics | 11.01 Mn | 11.01 Mn | - | -48.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.79% |
| Mar 31, 2026 | -77.78% |
| Dec 31, 2025 | -98.08% |
| Sep 30, 2025 | -118.98% |
| Jun 30, 2025 | -138.95% |
| Mar 31, 2025 | -99.08% |
| Dec 31, 2024 | -87.40% |
| Sep 30, 2024 | -82.49% |
| Jun 30, 2024 | -62.81% |
| Mar 31, 2024 | -47.09% |
| Dec 31, 2023 | -41.50% |
| Sep 30, 2023 | -41.15% |
| Jun 30, 2023 | -40.50% |
| Mar 31, 2023 | -36.74% |
| Dec 31, 2022 | -32.01% |
| Sep 30, 2022 | -29.34% |
| Jun 30, 2022 | -24.61% |
| Mar 31, 2022 | -23.27% |
| Dec 31, 2021 | -20.63% |
| Sep 30, 2021 | -15.26% |
API Access
Theriva Biologics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();